期刊文献+

糖尿病对充血性心力衰竭患者心率变异性的影响

Effect of Diabetes Mellitus on Heart Rate Variability in Patients with Congestive Heart Failure
下载PDF
导出
摘要 目的 :观察糖尿病是否会加重充血性心力衰竭 (CHF)患者的自主神经功能异常。方法 :对 35例糖尿病合并CHF和 4 5例非糖尿病CHF患者行 2 4h动态心电图检查 ,采用 2 4h时域和频域心率变异性方法来评价自主神经功能。结果 :两组有重要预后价值的HRV指标 (SDNN ,SDANN5及TP功率 )无差别。反映迷走神经活性的HRV指标 (pNN5 0 ,RMSSD及HF功率 )在两组有类似程度的降低。糖尿病组的LF明显低于非糖尿病组[(3.6 1± 0 .18)vs (4.0 9± 0 .2 1)In ms2 ,P =0 .0 4 ]。合并糖尿病组患者的LF/HF也明显低于非糖尿病组 [(2 .2± 0 .2 )vs (1.4± 0 .2 ) ,P =0 .0 0 1]。结论 :在CHF患者 ,合并的糖尿病不影响具有预后价值的HRV指标。此外 ,在CHF交感神经刺激增加的情况下 ,糖尿病不进一步降低迷走神经活性 ,但降低交感神经活性。 Objective:To determine if the severity of autonomic dysfunction in patients with chronic heart failure (CHF) are affected by the presence of diabetes. Methods: Holter ECGs from 35 diabetic patients and 45 nondiabetic controls with CHF were analyzed. The severity of autonomic dysfunction was assessed using 24-hour time- and frequency-domain HRV analysis. Results: Prognostically important HRV measures (SDNN, SDANN5, and total power) were not different between the two groups. Time- and frequency-domain parameters modulated by parasympathetic tone (pNN50, RMSSD, and HF power) were depressed to a similar degree in the diabetic and the nondiabetic groups. The low frequency power was significantly lower in diabetic patients [(3.61±0.18)vs (4.09±0 21) In-ms2,P=0.04]. The ratio of low to high frequency power was substantially lower in the diabetic group [(2 2±0.2) vs (1.4±0.2), P=0.001]. Conclusion: In the presence of CHF, HRV parameters that are most predictive of adverse outcome are similar in diabetic and nondiabetic patients. Furthermore, during increased sympathetic stimulation in the setting of heart failure, diabetes does not worsen parasympathetic withdrawal but may mitigate sympathetic activation.
出处 《广州医学院学报》 2004年第3期40-42,共3页 Academic Journal of Guangzhou Medical College
关键词 心力衰竭 充血性 糖尿病自主神经损害 心率变异性 congestive heart failure diabetic autonomic neuropathy heart rate variability
  • 相关文献

参考文献7

  • 1Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology.Heart rate variability: Standards of measurement, physiological interpretation and clinical use [ J ]. Circulation,1996, 93(5) :1043 - 1065.
  • 2Vinik AI, Maser RE, Mitchell BD, Freeman R. Diabetic autonomic neuropathy [ J ]. Diabetes Care, 2003,26(5):1553 -79.
  • 3Aronson D, Mittleman MA, Burger AJ. Measures of heart period variability as predictors of mortality in hospitalized patients with decompensated congestive heart failure [ J ].Am J Cardiol,2004,93 (1) :59 -63.
  • 4Stevens M J, Raffel DM, Allman KC, et al. Cardiac sympathetic dysinnervation in diabetes: Implications for enhanced cardiovascular risk [ J]. Circulation, 1998, 98 (10): 961- 968.
  • 5Malik M, Camm AJ. Components of heart rate variabilitywhat they really mean and what we really measure [ J ]. Am J Cardiol, 1993, 72 ( 11 ) :821 - 822.
  • 6Di Carli MF, Bianco-Batlles D, Landa ME, et al. Effects of autonomic neuropathy on coronary blood flow in patients with diabetes mellitus [ J ]. Circulation, 1999, 100 ( 8 ): 813-819.
  • 7Marchant B, Umachandran V, Stevenson R, et al. Silent myocardial ischemia: Role of subclinical neuropathy in patients with and without diabetes[J]. J Am Coll Cardiol,1993,22(5): 1433 - 1437.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部